Sapats S I, Heine H G, Trinidad L, Gould G J, Foord A J, Doolan S G, Prowse S, Ignjatovic J
CSIRO Livestock Industries, Australian Animal Health Laboratory, Geelong, VIC, Australia.
Arch Virol. 2003 Mar;148(3):497-515. doi: 10.1007/s00705-002-0931-2.
Phage-displayed recombinant antibody libraries derived from splenic mRNA of chickens immunized with an Australian strain of infectious bursal disease virus (IBDV) were constructed as single chain variable fragments (scFv) by either overlap extension polymerase chain reaction (PCR) or sequential ligation of the individual heavy (V(H)) and light (V(L)) chain variable gene segments. Sequential cloning of the individual V(H) and V(L) genes into a newly constructed pCANTAB-link vector containing the synthetic linker sequence (Gly(4)Ser)(3) was more efficient than cloning by overlap extension PCR, increasing the library size 500 fold. Eighteen IBDV specific antibodies with unique scFv sequences were identified after panning the library against the immunizing antigen. Eight of the clones contained an identical V(H) gene but unique V(L) genes. In ELISA analysis using a panel of Australian and overseas IBDV strains, one scFv antibody was able to detect all strains, whilst 3 others could discriminate between Australian and overseas strains, classical and variant strains and Australian field strains and vaccine strains. In addition, some scFvs showed significant neutralization titres in vitro. This report shows that generation of chicken antibodies in vitro by recombinant means has considerable potential for producing antibodies of diverse specificity and neutralizing capacity.
通过重叠延伸聚合酶链反应(PCR)或单个重链(V(H))和轻链(V(L))可变基因片段的顺序连接,构建了源自用澳大利亚传染性法氏囊病病毒(IBDV)株免疫的鸡脾脏mRNA的噬菌体展示重组抗体文库,作为单链可变片段(scFv)。将单个V(H)和V(L)基因顺序克隆到含有合成接头序列(Gly(4)Ser)(3)的新构建的pCANTAB-link载体中,比通过重叠延伸PCR克隆更有效,使文库大小增加了500倍。用免疫抗原淘选文库后,鉴定出18种具有独特scFv序列的IBDV特异性抗体。其中8个克隆含有相同的V(H)基因但独特的V(L)基因。在使用一组澳大利亚和海外IBDV株进行的ELISA分析中,一种scFv抗体能够检测所有毒株,而其他3种能够区分澳大利亚和海外毒株、经典毒株和变异毒株以及澳大利亚田间毒株和疫苗毒株。此外,一些scFv在体外显示出显著的中和效价。本报告表明,通过重组手段在体外产生鸡抗体在生产具有不同特异性和中和能力的抗体方面具有相当大的潜力。